Expedeon and Mologic Sign Supply and Licensing Agreement

July 27th, 2015

License covers use of Innova’s Lightning-Link and InnovaCoat GOLD technologies in Mologic’s kits and services Cambridge and Bedford, UK, 27 July 2015: Expedeon (Innova), a specialist provider of bioconjugation products and services, and Mologic, a specialist diagnostic development company and molecular reagent innovator, announced today the signing of a supply and licensing agreement for use…

View

Your preferred local currency is now